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This trial evaluated the reproductive performance in an early routine oes-
trus induction programme using two different PGF2α preparations in dairy cattle. 
D-cloprostenol sodium (n = 192; Group A) or dinoprost (n = 187; Group B) was 
administered between days 35 and 42 post partum. Also, a group of non-treated 
cows (n = 135; Group C) was included as control. Pedometers were used to detect 
oestrus, and also secondary oestrous signs and vaginal mucus quality were as-
sessed prior to artificial insemination (AI). When oestrus was not detected for 14 
days after PGF2α administration, the treatment was repeated, up to a maximum of 
three times. There were no differences between the study groups in oestrus detec-
tion (A = 73.48%, B = 73.01%, C = 79.26%; P = 0.428), good mucus quality (A = 
96.45%, B = 91.30%, C = 93.45%; P = 0.203) and the presence of mounting le-
sions (A = 98.58, B = 94.93%, C = 98.13; P = 0.414). First-service pregnancy 
rates were 19.78%, 15.64% and 32.03% in Groups A, B and C, respectively (P = 
0.003). There were no inter-group differences for the interval from parturition to 
first AI. However, a significantly shorter interval from parturition to conception 
(92.17 days, 99.45 days, 118.93 days; P = 0.002) and significantly less services 
per conception (2.12, 2.18, 2.66; P = 0.003) were observed in Groups A and B in 
comparison with Group C. The use of PGF2α resulted in better fertility in a repeti-
tive, routine postpartum programme, although no differences between D-
cloprostenol and dinoprost were detected.  
Key words: Oestrus cycle, prostaglandin F2 alpha, reproductive perform-
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The use of postpartum oestrus induction and synchronisation programmes 
has been widely studied to optimise the calving interval and thus increase the 
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economic profitability of the herd. It is essential to restore postpartum reproduc-
tive status as soon as possible, which is dictated largely by the resumption of 
hormonal cycling and uterine involution, both of which are in turn regulated by 
the negative energy balance of this phase (Walsh et al., 2011). The difficulties 
inherent in postpartum reproductive efficiency are often aggravated by an unac-
ceptably low rate of oestrus detection. 
Prostaglandin (PG) treatments have been designed to improve the repro-
ductive results after parturition by the use of, among others, single-dose admini-
stration, double-dose administration at 11- to 14-day intervals (Drillich et al., 
2000; Répási et al., 2005; Stötzel et al., 2012), or combination of PGs with other 
active ingredients such as progesterone and GnRH (Pursley et al., 1995; Ribeiro 
et al., 2012). The currently available PGs differ largely in terms of their molecu-
lar composition (Pursley et al., 2012). The efficacy of commercial PGs is a mat-
ter of some debate, and depends to a large degree on the speed at which they are 
metabolised and on their affinity for myometrial and corpus luteum (CL) cell-
membrane receptors (Re et al., 1994; Hirsbrunner et al., 1999). 
The aim of this prospective study was to compare the effects on reproductive 
efficiency of a luteolytic dose of D-cloprostenol and dinoprost tromethamine, 
both of which were routinely administered at 35–42 days postpartum and re-
peated each 14 days in a commercial dairy cattle farm, as a strategy for improv-
ing the reproductive performance in dairy farms. 
 
 
Materials and methods 
Herd description, animal selection and treatment protocol 
The present study was conducted in a commercial dairy farm with around 
1200 lactating Holstein cows, located in Southern Spain (Jaen). The animals were 
housed in stalls with open-air and sheltered areas and fed a balanced diet, in ac-
cordance with the NRC requirements. All cows were milked twice daily at 6:00 
and 17:00 h, with an average annual milk yield of 7500 kg per animal. A volun-
tary waiting period (VWP) of 35 days was established by selecting all cows at 
between 35 and 42 days post partum on the day when treatment commenced. 
Treatment was routinely administered every Monday; in cows not displaying 
oestrus, treatment was repeated 14 days later, up to a maximum of three times 
(Fig. 1). Cows were randomly assigned to two treatment groups: Group A (n = 
192) received 0.15 mg of D-cloprostenol (Dalmazin, Fatro Iberica, Italy) and 
Group B (n = 187) received 25 mg of dinoprost tromethamine (Dinolytic, Pfizer, 
Germany). Mean parity was 2.29 ± 0.94 in Group A and 2.79 ± 1.07 in Group B. A 
total of 135 cows under standard reproductive management, without hormonal 
treatment for oestrus induction, were included as a control (Group C), with a 
mean parity of 2.55 ± 0.97. Body condition score was ≥ 2.5 in all animals studied 
 OESTRUS INDUCTION USING REPETITIVE PGF2α POST PARTUM 81 
Acta Veterinaria Hungarica 63, 2015 
(scale 0–5 units; Edmonson et al., 1989). For artificial insemination (AI), pe-
dometers (Dairy Plan, Westfalia, Germany) were used to detect oestrus, which 
was recorded twice daily, during milking. Before AI, it was also recorded (i) 
whether cows showed typical oestrous signs on the back and hindquarters caused 
by scratches from other animals’ hooves during mounting, and (ii) whether vagi-
nal mucus, evaluated by vaginal examination, was adequate (abundant, clear, wa-
tery vaginal mucus was considered as good quality, and less abundant, thicker 
mucus was regarded as poor quality). Cows displaying purulent mucus consistent 
with endometritis were not inseminated. Pregnancy was diagnosed by rectal pal-
pation between 45 and 60 days after insemination. Cows that returned to oestrus 
following AI or that were not pregnant at the time of diagnosis were not eligible 
to re-enter the study for subsequent AI. 
 
Fig. 1. PGF2α schedule used to synchronise oestrus in postpartum dairy cows, indicating the times 
when oestrus detection and artificial insemination (AI) are carried out 
Data management and statistical analysis 
The following calculations were performed for both groups: oestrus detec-
tion rate (number of treated cows displaying oestrus), first-service pregnancy rate 
(number of cows becoming pregnant divided by the number of treated cows), 
first-service conception rate (number of cows diagnosed pregnant divided by the 
number of cows inseminated), percent of cows displaying oestrus with abundant 
and clear vaginal mucus, percent of cows displaying oestrus with typical oestrus-
related signs on back and hindquarters, interval from parturition to first AI, inter-
val from parturition to conception (days open) by 200 days, and services/ 
gestation (by 200 days). Chi-square test was used to compare proportions, while 
intervals were compared by analysis of variance (ANOVA) and when differences 
were significant (P ≤ 0.05), the Least Square Differences (LSD) test was per-
formed. Results were expressed as mean ± SD. Survival curves were used to show 
the proportion of cows that did not demonstrate oestrus (and were not insemi-
nated), and that did not conceive during the period of study. The statistical soft-
ware package SPSS 11.0 for Windows was used to perform statistical analyses. 
 
 
End of  
observation 
35–42 days 
CALVING 
TREATMENT TREATMENT TREATMENT
Oestrus detection and artificial insemination 
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Results 
No significant differences for oestrus detection rates were observed fol-
lowing the administration of D-cloprostenol or dinoprost, or in Group C 
(73.48%, 73.01% and 79.26%, respectively; P = 0.428). Figure 2 shows differ-
ences in the time elapsing to first AI (i.e. observed oestrus). Table 1 shows oes-
trus detection rates after the first, second and third prostaglandin administrations, 
where no inter-group differences were observed. In relation to the quality and 
quantity of cervical mucus at oestrus, largely abundant, clear and watery mucus 
was observed in 96.45% (136/141) of oestrous cows treated with D-cloprostenol, 
in 91.30% (126/138) of cows in the dinoprost tromethamine group, and in 
93.45% (100/107) in the non-treated group; the differences were not significant 
(P = 0.203) (Table 1). The percentage of cows in which pedometer-detected oes-
trus was accompanied by mounting lesions did not show treatment-related varia-
tion (A = 98.58%, B = 94.93%, C = 98.13%; P = 0.414). A total of 13 cows (2.7%) 
were excluded from the treated groups (5 from Group A and 8 from Group B) 
due to vaginal discharge consistent with endometritis, while 7 cows were excluded 
from the non-treated group. 
 
Fig. 2. Survival curves for days to first AI in dairy cows that were treated with D-cloprostenol  
(n = 192, grey line), dinoprost (n = 187, dashed line) or were left without treatment (n = 135, black 
line). There was no difference for the interval from parturition to first AI between groups. Day 0 
indicates the beginning of the PGF2α treatment or the voluntary waiting period (VWP) in the non-
treated group (day 35 after parturition) 
 
Overall first-service pregnancy rate was similar in Groups A and B (19.78% 
and 15.64%, respectively; Table 1), while Group C showed a significantly higher 
value (32.03%; P = 0.003). Cows showing oestrus after PGF2α treatments had a 
significantly lower (P = 0.007) percentage of pregnancies (26.24% and 20.29% in 
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Table 1 
Mean percentage of oestrus detection, presence of mounting lesions and vaginal mucus, and conception and pregnancy rates in postpartum dairy 
cows treated with different PGF2α until oestrus induction 
Treatment groups 
PGF2α treatments for oestrus induction 
D-cloprostenol Dinoprost Non-treated 
P value 
At first treatment     
Detected oestrus rate (%, number) 40.10 (77/192) 40.64 (76/187) – 0.917 
First-service conception rate (%, number) 10.94 (21/192) 8.02 (15/187) – 0.382 
First-service pregnancy rate (%, number) 27.27 (21/77) 19.73 (15/76) – 0.341 
At second treatment     
Detected oestrus rate (%, number) 38.26 (44/115) 36.93 (41/111) – 0.891 
First-service conception rate (%, number) 10.43 (12/115) 8.18 (9/111) – 0.648 
First-service pregnancy rate (%, number) 27.27 (12/44) 21.95 (9/41) – 0.621 
At third treatment     
Detected oestrus rate (%, number) 31.25 (20/64) 30.0 (21/70) – 1.00 
First-service conception rate (%, number) 6.25 (4/64) 5.7 (4/70) – 1.00 
First-service pregnancy rate (%, number) 20.00 (4/20) 19.04 (4/21) – 1.00 
Overall     
Detected oestrus rate (%, number) 73.48 (141/192) 73.01 (138/187) 79.26 (107/135) 0.428 
Adequate mucus (%, number) 96.45 (136/141) 91.30 (126/138) 93.45 (100/107) 0.203 
Mounting  lesions (%, number) 98.58 (139/141) 94.93 (131/138) 98.13 (105/107) 0.414 
First-service pregnancy rate (%, number) 19.78 (37/187)a 15.64 (28/179)a 32.03 (41/128)b 0.003 
First-service conception rate (%, number) 26.24 (37/141)a 20.29 (28/138)a 38.32 (41/107)b 0.007 
Open days  92.17 ± 43.36a 99.45 ± 57.54a 118.93 ± 74.32b 0.002 
Days to first AI 52.24 ± 12.38 54.67 ± 39.67 62.21 ± 45.62 0.137 
Number of AIs to pregnancy 2.12 ± 1.14a 2.18 ± 1.32a 2.66 ± 1.58b 0.002 
a, b: Different superscripts indicate significant differences between groups. AI: artificial insemination 
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Group A and Group B, respectively) than cows included in Group C (38.32%) 
during the period of the treatment, i.e. 80 (± 3) days after calving (Table 1). 
There were no inter-group differences for the interval from parturition to first AI 
(A = 52.24 ± 12.38; B = 54.67 ± 39.67; C = 62.21 ± 45.62; P = 0.137). In Groups 
A and B, cows needed fewer services to get pregnant than in Group C (2.12 ± 
1.14; 2.18 ± 1.32; 2.66 ± 1.58, respectively; P = 0.0031). The number of open days 
was significantly lower in Groups A and B than in Group C (92.17 ± 43.36 days 
and 99.45 ± 57.54 days, versus 118.93 ± 74.32 days, respectively; P = 0.002). 
 
 
Discussion 
When selecting routine postpartum treatment schedules, priority must be 
given to the ease of use, scheduling convenience, clinical efficacy and cost effec-
tiveness of the product. The final treatment choice will depend on the particular 
characteristics and purposes of the farm. Timed breeding systems are beneficial 
to the management of reproduction of dairy cows because they make it possible 
to schedule and control the insemination programme of lactating dairy cows. Re-
peated administration of PGF2α is one of the most widely used treatments (Ten-
hagen et al., 2000). Therefore, oestrus synchronisation programmes should aim 
to control the follicular waves as well as the onset of oestrus and ovulation (Al-
nimer et al., 2009), in order to improve the oestrus detection and the pregnancy 
rates (Pankowski et al., 1995; Bissinoto and Santos, 2012). The results obtained 
in this study confirm that repetitive administration of D-cloprostenol achieves 
slightly better reproductive rates compared to dinoprost tromethamine, although 
the differences were not significant. In a similar study, Pursley et al. (2012) ob-
served that differences between the two PGF2α products were really apparent in 
first-parity cows. 
After routine administration every 14 days, D-cloprostenol and dinoprost 
tromethamine proved equally effective in achieving synchronised oestrus induc-
tion in lactating dairy cows. Oestrus detection rates obtained with both PGF2α 
products were higher than those reported in previous trials by Momcilovic et al. 
(1998) or Pursley et al. (2012) (52% and 46.7%, respectively), and a decline in 
oestrus detection rates after each successive dose of PGF2α was observed. Ani-
mals failing to display oestrus after treatment should be further examined to as-
certain the reason for the absence of oestrus. 
Both studied PGs produced abundant, clear cervical mucus, perhaps due to 
an improved PGF2α-mediated follicular growth (Armstrong, 1981) and by the 
enhancement of oestradiol and LH secretion (Tsiligianni et al., 2001). Whether 
PGs have direct effects on follicular growth prior to the LH surge to initiate ovu-
lation in livestock is unknown, but PGF2α increases pituitary responsiveness to 
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GnRH to release LH in the postpartum cow (Weems et al., 2006). A very high 
proportion of cows detected in oestrus by pedometer showed mounting lesions. 
The results suggest that if this working protocol is adopted, the reproductive effi-
ciency can be improved even in herds that use visual observation to detect oes-
trus. Although physical differences in cervical mucus quality are not believed to 
directly affect fertility (Tsiligianni et al., 2001), the results suggest that abundant, 
clear mucus may serve as an indicator of oestrus in farms using oestrus detection 
by observation, and may enable the timing of AI to be optimised. Similarly, 
PGF2α administration leads to improved oestrus detection rates, since the number 
of mountings increases with the number of animals displaying oestrus, due to 
behavioural and pheromonal interactions. The increase in oestrous behaviour as-
sociated with more cows in oestrus could increase the number of oestrous cows 
detected with infrequent visual observation (Floyd et al., 2009). 
At the onset of oestrus, 2.7% of the treated cows displayed whitish speck-
led cervical mucus consistent with genital infection. This rate is lower than the 
15.6% reported by Drillich et al. (2000). According to Gautam et al. (2010), 
25.3% of cows with postpartum endometritis (clinical or subclinical) during days 
15 to 60 had persistence or recurrence of endometritis between days 61 and 150. 
This suggests that the repeated administration of PGF2α outlined here is not only 
an efficient tool for oestrus induction and synchronisation, but may also have a 
therapeutic effect on mild (undetected) endometritis and thus enhance reproduc-
tive efficiency (Knutti et al., 2000; Tenhagen et al., 2001). The use of PGF2α has 
also been described for treating subclinical endometritis (Janowski et al., 2011). 
However, the above-mentioned treatment sometimes does not affect the preva-
lence of subclinical endometritis, although it increases first-service pregnancy 
per AI (Galvão et al., 2009). 
In both treated groups, oestrus distribution was highly heterogeneous, 
similarly as reported by Seguin et al. (1985), since follicular development was 
not controlled and maximum frequency of onset was recorded around 3 days af-
ter treatment, in agreement with the findings of LeBlanc et al. (1998). One factor 
limiting the efficacy of the repeat-dose PGF2α protocol was the considerable 
variation of ovulation time, which rendered fixed-time AI impossible (Keister et 
al., 1999). A recurring doubt is whether or not the use of PGF2α has a negative 
effect on fertility, due to either incomplete luteolysis or interference of the proto-
col with follicular dynamics. Lauderdale et al. (1974) and Drillich et al. (2000) 
deny the existence of any such negative effect. Minor improvements in preg-
nancy rates are proof enough to justify the financial benefits of using PGF2α 
treatments (Plunkett et al., 1984). Treatment with additional PGF2α increased the 
percentage of cows that have completed luteal regression but it did not have a de-
tectable effect on pregnancies per AI (Brusveen et al., 2009). 
In this study, it was observed that the first-service conception rate using 
D-cloprostenol was slightly higher than that obtained using dinoprost tro-
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methamine, and similar as reported by others (Momcilovic et al., 1998; Keister et 
al., 1999; Drillich et al., 2000), although protocols differed between studies. In 
contrast, other studies concluded that both products were equally effective lute-
olysins and produced similar pregnancy outcomes in lactating dairy cows (Ste-
venson and Phatak, 2010). Cairoli et al. (2006) found no differences in concep-
tion rates between cloprostenol and dinoprost in cows inseminated at observed 
oestrus. In agreement with the findings of the present study, Salverson et al. 
(2002) reported that following administration of PGF2α (dinoprost and racemic 
cloprostenol) in combination with MGA, the oestrus synchronisation and fertility 
results were similar for the two prostaglandins. 
A number of studies report that the fertility rates obtained after routine 
administration of PGF2α with no prior animal examination are higher than those 
obtained following administration of PGF2α when a CL is detected by rectal pal-
pation (Kristula et al., 1992; Heuwieser et al., 1997; Répási et al., 2014) or when 
high progesterone levels are measured (Heuwieser et al., 1997). In other studies, 
the accuracy of rectal palpation for the presence of a functional CL was 73.9%, 
which confirms the unreliability of rectal palpation alone to assess the functional-
ity of the CL (Cairoli et al., 2006). 
Cows included in Groups A and B required further 20 days to get pregnant 
in comparison with those in Group C, which represents a considerable financial 
drain. Knutti et al. (2000) observed that the interval between parturition and con-
ception in cows with mild endometritis was shorter in non-cycling cows treated 
with PGF2α than in cycling herdmates, but not significant differences were de-
tected. This finding would seem to further highlight the advantages of the breed-
ing programme mentioned here. No inter-group differences were observed in the 
interval between calving and first insemination. The interval was relatively short 
in both treated groups, thus allowing conception to take place sooner, and ena-
bling cows with reproductive disorders to be treated earlier. In contrast to the 
findings of Revah et al. (1989), repeated administration of PGF2α reduced the 
number of services required for the cow to become pregnant, thus underlining 
again the positive effect of PGF2α on fertility. 
In conclusion, the results obtained in this study demonstrate that routine 
postpartum administration of prostaglandins is a viable working protocol for 
commercial dairy farms with a high-quality oestrus detection system, enabling 
improved oestrus detection, concentration of AI and enhanced breeding effi-
ciency, and significant differences between natural and synthetic PGF2α were not 
detected in terms of the results achieved. 
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